Effectiveness and cost-effectiveness of sector-independent treatment coordination for people with substance-related disorders following an online assessment (ASSIST): study protocol for a randomized controlled trial.
Addiction,
Cost-effectiveness
Online assessment,
Sector-independent treatment coordination,
Substance use disorder,
Substance-related problems
Treatment allocation,
e-Health, Satisfaction,
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
01 Jun 2022
01 Jun 2022
Historique:
received:
10
02
2022
accepted:
23
04
2022
entrez:
1
6
2022
pubmed:
2
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
The implementation of person-centred, need-oriented and flexible care for people with substance-related problems is often insufficient, in large part due to the complexity of addiction support services among different providers. A standardized online assessment and subsequent sector-independent treatment coordination could provide individuals with more appropriate services, thereby making better use of individual services and leading to a more effective addiction support system as a whole. The aim of this study is to determine the effectiveness and cost-effectiveness of sector-independent treatment coordination following an online assessment, in comparison with the current standard of care and treatment process in Germany. The sample size of this randomized, controlled trial has been set to a total of 400 participants with substance-related problems. Participants living in Stuttgart, Germany, will be randomly allocated to (1) the intervention group with immediate online assessment and subsequent sector-independent treatment coordination (ASSIST) or (2) the waitlist group. Participants in the waitlist group will initially remain in usual care and only be provided with the online assessment 6 months later. Short-term effects (over 2 months) and medium-term effects (over 6 months) of ASSIST will be compared between the intervention and the waitlist groups. The primary outcome is improved treatment satisfaction. Secondary outcomes include improved subjective quality of life and empowerment, reductions in patients' substance use, unmet needs and illness-related clinical and social impairment. Health economic evaluation as well as quantitative and qualitative process evaluations will be conducted. The results of this study are expected to provide information on whether sector-independent treatment coordination following an online assessment contributes to improved health care service provision for people with substance-related problems. This randomized controlled trial will help identify facilitators and barriers to the sustainable implementation of a cross-sectoral care concept in substance abuse services. German Clinical Trial Register DRKS00026996 . Registered on 29 October 2021.
Sections du résumé
BACKGROUND
BACKGROUND
The implementation of person-centred, need-oriented and flexible care for people with substance-related problems is often insufficient, in large part due to the complexity of addiction support services among different providers. A standardized online assessment and subsequent sector-independent treatment coordination could provide individuals with more appropriate services, thereby making better use of individual services and leading to a more effective addiction support system as a whole. The aim of this study is to determine the effectiveness and cost-effectiveness of sector-independent treatment coordination following an online assessment, in comparison with the current standard of care and treatment process in Germany.
METHODS
METHODS
The sample size of this randomized, controlled trial has been set to a total of 400 participants with substance-related problems. Participants living in Stuttgart, Germany, will be randomly allocated to (1) the intervention group with immediate online assessment and subsequent sector-independent treatment coordination (ASSIST) or (2) the waitlist group. Participants in the waitlist group will initially remain in usual care and only be provided with the online assessment 6 months later. Short-term effects (over 2 months) and medium-term effects (over 6 months) of ASSIST will be compared between the intervention and the waitlist groups. The primary outcome is improved treatment satisfaction. Secondary outcomes include improved subjective quality of life and empowerment, reductions in patients' substance use, unmet needs and illness-related clinical and social impairment. Health economic evaluation as well as quantitative and qualitative process evaluations will be conducted.
DISCUSSION
CONCLUSIONS
The results of this study are expected to provide information on whether sector-independent treatment coordination following an online assessment contributes to improved health care service provision for people with substance-related problems. This randomized controlled trial will help identify facilitators and barriers to the sustainable implementation of a cross-sectoral care concept in substance abuse services.
TRIAL REGISTRATION
BACKGROUND
German Clinical Trial Register DRKS00026996 . Registered on 29 October 2021.
Identifiants
pubmed: 35650629
doi: 10.1186/s13063-022-06343-4
pii: 10.1186/s13063-022-06343-4
pmc: PMC9156834
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
448Subventions
Organisme : Federal Joint Committee (DE)
ID : 01NVF19016
Informations de copyright
© 2022. The Author(s).
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
PLoS One. 2019 Aug 28;14(8):e0221153
pubmed: 31461466
Addiction. 1995 May;90(5):607-14
pubmed: 7795497
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Dtsch Arztebl Int. 2019 Sep 2;116(35-36):577-584
pubmed: 31587705
JAMA Intern Med. 2014 Mar;174(3):399-407
pubmed: 24276929
BMC Psychiatry. 2016 May 23;16:159
pubmed: 27216151
Psychiatr Serv. 1998 May;49(5):573-5
pubmed: 9603565
J Psychosom Res. 2015 Apr;78(4):352-5
pubmed: 25498316
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Psychother Psychosom Med Psychol. 1989 Jul;39(7):248-55
pubmed: 2762479
Eur Addict Res. 2020;26(3):109-121
pubmed: 32074597
Addiction. 2011 Oct;106(10):1715-7
pubmed: 21793970
Psychol Addict Behav. 2014 Mar;28(1):154-62
pubmed: 23276315
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
Z Kinder Jugendpsychiatr Psychother. 2020 Nov;48(6):448-452
pubmed: 32208050
Stat Methods Med Res. 2007 Jun;16(3):219-42
pubmed: 17621469
Psychopathology. 2007;40(2):116-25
pubmed: 17215598
PLoS One. 2009 Dec 17;4(12):e8343
pubmed: 20020047
Psychiatr Prax. 2009 Mar;36(2):72-8
pubmed: 18924060
BMC Psychiatry. 2014 Oct 14;14:286
pubmed: 25312546
Psychiatr Prax. 2001 Oct;28 Suppl 2:S84-90
pubmed: 11605129
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
Addiction. 2010 May;105(5):862-71
pubmed: 20331557
Eval Program Plann. 1982;5(3):233-7
pubmed: 10259963
Pain Rep. 2017 May 12;2(3):e599
pubmed: 29392214
J Health Commun. 2017 May;22(5):413-432
pubmed: 28394729
Psychiatr Prax. 2001 Oct;28 Suppl 2:S79-83
pubmed: 11605128
Gesundheitswesen. 2004 Feb;66(2):114-20
pubmed: 14994210